235 related articles for article (PubMed ID: 29535359)
1. Eya3 partners with PP2A to induce c-Myc stabilization and tumor progression.
Zhang L; Zhou H; Li X; Vartuli RL; Rowse M; Xing Y; Rudra P; Ghosh D; Zhao R; Ford HL
Nat Commun; 2018 Mar; 9(1):1047. PubMed ID: 29535359
[TBL] [Abstract][Full Text] [Related]
2. Biochemical characterization of the Eya and PP2A-B55α interaction.
Alderman C; Anderson R; Zhang L; Hughes CJ; Li X; Ebmeier C; Wagley ME; Ahn NG; Ford HL; Zhao R
J Biol Chem; 2024 May; ():107408. PubMed ID: 38796066
[TBL] [Abstract][Full Text] [Related]
3. The Eya phosphatase: Its unique role in cancer.
Zhou H; Zhang L; Vartuli RL; Ford HL; Zhao R
Int J Biochem Cell Biol; 2018 Mar; 96():165-170. PubMed ID: 28887153
[TBL] [Abstract][Full Text] [Related]
4. Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55alpha regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt.
Kuo YC; Huang KY; Yang CH; Yang YS; Lee WY; Chiang CW
J Biol Chem; 2008 Jan; 283(4):1882-92. PubMed ID: 18042541
[TBL] [Abstract][Full Text] [Related]
5. EYA1's Conformation Specificity in Dephosphorylating Phosphothreonine in Myc and Its Activity on Myc Stabilization in Breast Cancer.
Li J; Rodriguez Y; Cheng C; Zeng L; Wong EYM; Xu CY; Zhou MM; Xu PX
Mol Cell Biol; 2017 Jan; 37(1):. PubMed ID: 27795300
[TBL] [Abstract][Full Text] [Related]
6. Eya3 promotes breast tumor-associated immune suppression via threonine phosphatase-mediated PD-L1 upregulation.
Vartuli RL; Zhou H; Zhang L; Powers RK; Klarquist J; Rudra P; Vincent MY; Ghosh D; Costello JC; Kedl RM; Slansky JE; Zhao R; Ford HL
J Clin Invest; 2018 Jun; 128(6):2535-2550. PubMed ID: 29757193
[TBL] [Abstract][Full Text] [Related]
7. Protein phosphatase 2A regulatory subunit B56alpha associates with c-myc and negatively regulates c-myc accumulation.
Arnold HK; Sears RC
Mol Cell Biol; 2006 Apr; 26(7):2832-44. PubMed ID: 16537924
[TBL] [Abstract][Full Text] [Related]
8. Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer.
Janghorban M; Farrell AS; Allen-Petersen BL; Pelz C; Daniel CJ; Oddo J; Langer EM; Christensen DJ; Sears RC
Proc Natl Acad Sci U S A; 2014 Jun; 111(25):9157-62. PubMed ID: 24927563
[TBL] [Abstract][Full Text] [Related]
9. Protein phosphatase 2A is regulated by protein kinase Cα (PKCα)-dependent phosphorylation of its targeting subunit B56α at Ser41.
Kirchhefer U; Heinick A; König S; Kristensen T; Müller FU; Seidl MD; Boknik P
J Biol Chem; 2014 Jan; 289(1):163-76. PubMed ID: 24225947
[TBL] [Abstract][Full Text] [Related]
10. All eyes on Eya: A unique transcriptional co-activator and phosphatase in cancer.
Hughes CJ; Alderman C; Wolin AR; Fields KM; Zhao R; Ford HL
Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189098. PubMed ID: 38555001
[TBL] [Abstract][Full Text] [Related]
11. Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal Adenocarcinoma.
Allen-Petersen BL; Risom T; Feng Z; Wang Z; Jenny ZP; Thoma MC; Pelz KR; Morton JP; Sansom OJ; Lopez CD; Sheppard B; Christensen DJ; Ohlmeyer M; Narla G; Sears RC
Cancer Res; 2019 Jan; 79(1):209-219. PubMed ID: 30389701
[TBL] [Abstract][Full Text] [Related]
12. A tumor suppressor role for PP2A-B56alpha through negative regulation of c-Myc and other key oncoproteins.
Arnold HK; Sears RC
Cancer Metastasis Rev; 2008 Jun; 27(2):147-58. PubMed ID: 18246411
[TBL] [Abstract][Full Text] [Related]
13. Protein phosphatase 2A activation as a therapeutic strategy for managing MYC-driven cancers.
Farrington CC; Yuan E; Mazhar S; Izadmehr S; Hurst L; Allen-Petersen BL; Janghorban M; Chung E; Wolczanski G; Galsky M; Sears R; Sangodkar J; Narla G
J Biol Chem; 2020 Jan; 295(3):757-770. PubMed ID: 31822503
[TBL] [Abstract][Full Text] [Related]
14. Peroxynitrite promotes serine-62 phosphorylation-dependent stabilization of the oncoprotein c-Myc.
Raman D; Chong SJF; Iskandar K; Hirpara JL; Pervaiz S
Redox Biol; 2020 Jul; 34():101587. PubMed ID: 32512497
[TBL] [Abstract][Full Text] [Related]
15. Selective PP2A Enhancement through Biased Heterotrimer Stabilization.
Leonard D; Huang W; Izadmehr S; O'Connor CM; Wiredja DD; Wang Z; Zaware N; Chen Y; Schlatzer DM; Kiselar J; Vasireddi N; Schüchner S; Perl AL; Galsky MD; Xu W; Brautigan DL; Ogris E; Taylor DJ; Narla G
Cell; 2020 Apr; 181(3):688-701.e16. PubMed ID: 32315618
[TBL] [Abstract][Full Text] [Related]
16. Restricted protein phosphatase 2A targeting by Merkel cell polyomavirus small T antigen.
Kwun HJ; Shuda M; Camacho CJ; Gamper AM; Thant M; Chang Y; Moore PS
J Virol; 2015 Apr; 89(8):4191-200. PubMed ID: 25631078
[TBL] [Abstract][Full Text] [Related]
17. B56α subunit of protein phosphatase 2A mediates retinoic acid-induced decreases in phosphorylation of endothelial nitric oxide synthase at serine 1179 and nitric oxide production in bovine aortic endothelial cells.
Park JH; Sung HY; Lee JY; Kim HJ; Ahn JH; Jo I
Biochem Biophys Res Commun; 2013 Jan; 430(2):476-81. PubMed ID: 23237802
[TBL] [Abstract][Full Text] [Related]
18. The multi-functional eyes absent proteins.
Hegde RS; Roychoudhury K; Pandey RN
Crit Rev Biochem Mol Biol; 2020 Aug; 55(4):372-385. PubMed ID: 32727223
[TBL] [Abstract][Full Text] [Related]
19. Activation of p107 by fibroblast growth factor, which is essential for chondrocyte cell cycle exit, is mediated by the protein phosphatase 2A/B55α holoenzyme.
Kurimchak A; Haines DS; Garriga J; Wu S; De Luca F; Sweredoski MJ; Deshaies RJ; Hess S; Graña X
Mol Cell Biol; 2013 Aug; 33(16):3330-42. PubMed ID: 23775125
[TBL] [Abstract][Full Text] [Related]
20. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells.
Yeh E; Cunningham M; Arnold H; Chasse D; Monteith T; Ivaldi G; Hahn WC; Stukenberg PT; Shenolikar S; Uchida T; Counter CM; Nevins JR; Means AR; Sears R
Nat Cell Biol; 2004 Apr; 6(4):308-18. PubMed ID: 15048125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
